Published Date: 06 Mar 2023
A new study by Diego Adão and team has shown that using erythromycin before the exam can improve your ability to see your vision.
Read Full NewsFor more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled out diabetes before finally ...
A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give ...
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by human papillomavirus (HPV), a viral infection that spreads through sexual contact.
1.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
2.
New Zealand and Australian breast cancer rates among the highest in the world, global study finds
3.
The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.
4.
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis
5.
Best foot forward—chemo care should include podiatry, say researchers
1.
Introduction to Immune Thrombocytopenic Purpura
2.
Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern
3.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
4.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
5.
Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
5.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation